Supradent Drugs Limited
Founded in 2008 and headquartered in Tamil Nadu, India.
2008 | Dharmapuri, Tamil Nadu (India) | Active
Supradent Drugs Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 1.07 M
- Company Age 16 Year, 8 Months
- Last Filing with ROC 31 Mar 2012
- Open Charges ₹ 3.00 M
About Supradent Drugs
Supradent Drugs Limited (SDL) is a Public Limited Indian Non-Government Company incorporated in India on 23 June 2008 and has a history of 16 years and eight months. Its registered office is in Dharmapuri, Tamil Nadu, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2012. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.07 M.
The company currently has active open charges totaling ₹3.00 M.
Venkatesan Goppi, Nallakannu Prabakar, and Radhakrishnan Murali serve as directors at the Company.
Company Details
- Location
Dharmapuri, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24230TZ2008PLC017228
- Company No.
017228
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
23 Jun 2008
- Date of AGM
29 Sep 2012
- Date of Balance Sheet
31 Mar 2012
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Chemicals
Pharmaceuticals
Supradent Drugs Limited
Explore comprehensive data for Supradent Drugs Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Supradent Drugs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkatesan Goppi  | Managing Director | 23-Jun-2008 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nallakannu Prabakar | Director | 23-Jun-2008 | Current |
| Radhakrishnan Murali | Director | 01-Jun-2009 | Current |
Financial Performance of Supradent Drugs.
Enhance accessibility to Supradent Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Supradent Drugs?
Unlock access to Supradent Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Regenix Drugs LimitedRadhakrishnan Murali is a mutual person
- Visisht Health Care Centre Private Limited
Radhakrishnan Murali is a mutual person
Charges (Loans)
Open Charges
₹3.00 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Indian Bank : 0.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Oct 2011 | Indian Bank | ₹3.00 M | Open |
How Many Employees Work at Supradent Drugs?
Unlock and access historical data on people associated with Supradent Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Supradent Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Supradent Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Supradent Drugs
Recent activity within the organization
- Annual General Meeting
Supradent Drugs Limited last Annual general meeting of members was held on 29 Sep 2012 as per latest MCA records.
- Balance Sheet
Supradent Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2012 with Roc Coimbatore.
- Charges
A charge with Indian Bank amounted to Rs. 3.00 M with Charge ID 10317206 was registered on 14 Oct 2011.
- Director Appointment
Radhakrishnan Venu Murali was appointed as a Director was appointed as a Director on 01 Jun 2009 & has been associated with this company since 15 years 9 months .
- Director Appointment
Venkatesan Goppi was appointed as a Managing Director was appointed as a Managing Director on 23 Jun 2008 & has been associated with this company since 16 years 8 months .
- Director Appointment
Nallakannu Baskara Prabakar was appointed as a Director was appointed as a Director on 23 Jun 2008 & has been associated with this company since 16 years 8 months .
Frequently asked questions
What is the Incorporation or founding date of Supradent Drugs Limited?
Supradent Drugs Limited was incorporated on 23 Jun 2008.
What is authorized share capital and paid-up capital of Supradent Drugs Limited?
The authorized share capital of Supradent Drugs Limited is ₹ 2.50 M and paid-up capital is ₹ 1.07 M.
Who are the current board members & directors of Supradent Drugs Limited?
Currently 3 directors are associated with Supradent Drugs Limited.
- Venkatesan Goppi
- Nallakannu Baskara Prabakar
- Radhakrishnan Venu Murali
What is the registered address of Supradent Drugs Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Supradent Drugs Limited is 15/3 South Narasimachary Street India, Dharmapuri, Tamil Nadu, 636701.
What is the corporate identification number (CIN) and company number of Supradent Drugs Limited?
The corporate identification number (CIN) of Supradent Drugs Limited is U24230TZ2008PLC017228 and the company number is 017228 as per Ministry of Corporate Affairs (MCA).
What are the total open charges for Supradent Drugs Limited?
As per the financial statements for fiscal Year 0, The total open charges for Supradent Drugs Limited amount to ₹ 3.00 M.
When was the last Balance Sheet of Supradent Drugs Limited filed with the ROC?
The most recent Balance Sheet for Supradent Drugs Limited was filed with the ROC on 31 Mar 2012.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
MH
Mohamed HamidDirector